EuclidSR Partners

What is EuclidSR Partners?

EuclidSR Partners is a seasoned venture capital firm with a focus on pioneering advancements within life sciences, convergence technology, and information technology sectors. The firm operates with a substantial investment fund, boasting a capacity to allocate up to $50,000,000 and a minimum investment threshold of $5,400,000, which allows them to take strategic positions in their portfolio companies.

Since its inception, EuclidSR Partners has managed to create a robust investment platform, building upon a legacy that stretches back over thirty years, with the original Euclid Partners laying the foundation for the firm’s current iteration. The firm prides itself on leveraging the extensive experience garnered not only from its venture capital endeavors but also drawing on the insights from two decades of corporate pharmaceutical venture investing, particularly through its affiliation with S.R.

One, Limited. Their investment thesis capitalizes on the junction of scientific discovery and technological innovation, aiming to propel businesses that stand at the forefront of their industries.

With a $250 million venture partnership, EuclidSR Partners supports companies from early to growth stages, providing not just capital but also strategic guidance to navigate the complex market dynamics and regulatory landscapes inherent to their focused sectors. Their operational history is marked by a deliberate approach to investing, targeting opportunities where their deep-seated knowledge and industry connections can actively enhance value creation.